Profiles

Mohsen Afarideh, MD MPH

Department of Dermatology, Mayo Clinic

Verified email at mayo.edu

Cited by 74830

Dermatology Epidemiology Therapeutic Targets Randomized Controlled Trials

Rui Su

City of Hope

Verified email at coh.org

Cited by 11290

Leukemia Epitranscriptomics Therapeutic targets Drug development Immune response

Kalavathy Ramasamy

Universiti Teknologi MARA

Verified email at salam.uitm.edu.my

Cited by 6810

Therapeutic targets

Mark Avigan

Associate Office Director, FDA & Professor (Adjunct), Georgetown U. School of Medicine

Verified email at fda.hhs.gov

Cited by 6290

Liver Disease Molecular Science Therapeutic targets Drug-induced liver injury

Yong Weon Yi, Ph.D.

College of Medicine, Dankook University

Verified email at dankook.ac.kr

Cited by 3290

protein kinase inhibitors therapeutic targets extracellular vesicles anticancer triple negative breast cancer

Bashdar Mahmud Hussen

College of Pharmacy, Hawler Medical University, Kurdistan region, Iraq

Verified email at hmu.edu.krd

Cited by 3246

Cancer Non-coding RNA Therapeutic targets

Julie Decock

Qatar Biomedical Research Institute (QBRI)

Verified email at hbku.edu.qa

Cited by 2943

breast cancer cancer testis antigens tumor-immune ecosystem therapeutic targets

Paul Nguewa

Universidad de Navarra

Verified email at unav.es

Cited by 2258

leishmania drug therapeutic targets cancer

Feiya Li

Gladstone Institute

Verified email at gladstone.ucsf.edu

Cited by 1399

heart development therapeutic targets cardiovascular various diseases biomarker

Kesmic Jackson

Verified email at dendreon.com

Cited by 564

Bioassays Biomarkers Therapeutic Targets Immune Response Methylation

1 - 10